Translate
Fulgent Genetics Inc
About
Fulgent Genetics Inc (NASDAQ:FLGT) — investor relations, events, news, and company updates on 6ix.
Latest News
Apr 22 2026
Fulgent Selected to Present Rapid Oral Abstract Within the Head and Neck Cancer Track Session at the 2026 ASCO Annual Meeting
Apr 16 2026
Fulgent to Announce First Quarter 2026 Financial Results on Friday, May 1, 2026
Mar 17 2026
Fulgent Genetics Completes Acquisition of Bako Diagnostics and StrataDx
Feb 27 2026
Fulgent Reports Fourth Quarter and Full Year 2025 Financial Results
Feb 12 2026
Fulgent to Announce Fourth Quarter and Full Year 2025 Financial Results on Friday, February 27, 2026
Financials
Revenue
$322.67 M
Market Cap
$525.3 M
EPS
-1.97